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We report the case of a 13 year old girl with SLE initially
treated with hydroxycloroquine for a mainly mucocutane-
ous involvement.
Four months from onset, she presented renal involvement
and an acute hemoptysis and she was admitted to our
pediatric department. She also presented fever and abnor-
mal laboratory findings (high serum creatinine level,
severe proteinuria, Hb of 6.4 g/dl, high titre specific
autoantibodies, low C3 and C4 levels).
Kidney biopsy underlined stage 4a lupic nephropathy;
chest X-ray and CT scan showed diffused alveolar involve-
ment, as for pulmonary hemorrhage. Cerebral SPECT
showed abnormalities consistent with neurolupus. The
patient underwent blood transfusion, and was treated
with high doses of metilprednidsolone plus cyclophos-
phamide. Due to refractory anemia and worsening of res-
piratory symptoms (dispnoea with low peripheral oxygen
saturation), she was additionally treated with 3 courses of
Rituximab, and two further blood transfusions, with clin-
ical stabilization but no major amelioration. After one
week, severe clinical worsening with important dyspnoea,
cutaneous pallor, poor general condition, low peripheral
oxygen saturation (78%) was present: Hb level was 4 g/dl,
chest X-ray showed worsened alveolar involvement. The
patient was treated with 3 courses of plasmapheresis and
two blood transfusions, with immediate response of the
respiratory symptoms, recovery from anemia and marked
improvement of the chest X-ray.
Pulmonary hemorrhage is a severe complication in SLE
associated with high mortality. It is described in 5–6% of
patients, presenting with anemia, hemoptysis, respiratory
symptoms and characteristic changes in chest imaging.
We suggest plasmapheresis as an effective treatment to be
considered promptly when suspecting this life-threaten-
ing complication.
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